Thank you, Madam Chair.
Thanks to all the scientists for being here this afternoon to give us a perspective that is a little different from what we have already heard.
Dr. Ouellette, from what you say, the research community was not really consulted. There was just an information session.
Dr. Matlashewski, you tell us that, in the scientific community, there are still a huge number of questions and a huge fear that laboratory activities will be reduced or compromised.
Assuming that what the Public Health Agency of Canada tells us is true, that the regulatory framework is going to be constructed after extensive consultation and that all stakeholders are going to be met with and reassured, and considering what we know about these consultations and what has been done in the past, I wonder whether you would not consider that only real solution is to completely remove all mention of Level 2 pathogens from the bill. The regulations could then be prepared quicker and more precisely. You explained that Level 2 human pathogens are in no way comparable to Level 3 and 4 pathogens.